130 related articles for article (PubMed ID: 24111500)
1. Body temperature and major neurological improvement in tPA-treated stroke patients.
Kvistad CE; Thomassen L; Waje-Andreassen U; Logallo N; Naess H
Acta Neurol Scand; 2014 May; 129(5):325-9. PubMed ID: 24111500
[TBL] [Abstract][Full Text] [Related]
2. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study.
Naess H; Idicula T; Lagallo N; Brogger J; Waje-Andreassen U; Thomassen L
Acta Neurol Scand; 2010 Dec; 122(6):414-7. PubMed ID: 20199522
[TBL] [Abstract][Full Text] [Related]
3. Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke.
Yaghi S; Hinduja A; Bianchi N
Int J Neurosci; 2016; 126(1):67-9. PubMed ID: 25562545
[TBL] [Abstract][Full Text] [Related]
4. Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?
Kvistad CE; Khanevski A; Nacu A; Thomassen L; Waje-Andreassen U; Naess H
Vasc Health Risk Manag; 2014; 10():49-54. PubMed ID: 24482573
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
6. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
[TBL] [Abstract][Full Text] [Related]
7. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
8. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
de Ridder I; den Hertog H; van Gemert M; Dippel D; van der Worp B;
Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998
[TBL] [Abstract][Full Text] [Related]
9. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
Kim SH; Saver JL
Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
[TBL] [Abstract][Full Text] [Related]
10. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
11. Major neurologic improvement following endovascular recanalization therapy for acute ischemic stroke.
Prabhakaran S; Chen M; Choi JH; Mangla S; Lavine SD; Pile-Spellman J; Meyers PM; Chong JY
Cerebrovasc Dis; 2008; 25(5):401-7. PubMed ID: 18349533
[TBL] [Abstract][Full Text] [Related]
12. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
13. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
14. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion?
Sylaja PN; Dzialowski I; Puetz V; Eliasziw M; Hill MD; Krol A; O'Reilly C; Demchuk AM
Neurol India; 2009; 57(6):739-43. PubMed ID: 20139502
[TBL] [Abstract][Full Text] [Related]
15. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring.
Alexandrov AV; Demchuk AM; Felberg RA; Christou I; Barber PA; Burgin WS; Malkoff M; Wojner AW; Grotta JC
Stroke; 2000 Mar; 31(3):610-4. PubMed ID: 10700493
[TBL] [Abstract][Full Text] [Related]
16. Safety of off-label stroke treatment with tissue plasminogen activator.
Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
[TBL] [Abstract][Full Text] [Related]
17. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
[TBL] [Abstract][Full Text] [Related]
18. Body temperature and response to thrombolytic therapy in acute ischaemic stroke.
Millán M; Grau L; Castellanos M; Rodríguez-Yáñez M; Arenillas JF; Nombela F; Pérez de la Ossa N; López-Manzanares L; Serena J; Castillo J; Dávalos A
Eur J Neurol; 2008 Dec; 15(12):1384-9. PubMed ID: 19049558
[TBL] [Abstract][Full Text] [Related]
19. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
20. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
Dowlatshahi D; Hakim A; Fang J; Sharma M;
Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
